T 0867/23 (Cariprazine for treating primary negative symptoms of schizophrenia / RICHTER GEDEON NYRT.) of 21.01.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T086723.20250121
- Date of decision
- 21 January 2025
- Case number
- T 0867/23
- Petition for review of
- -
- Application number
- 13805597.5
- IPC class
- A61P 25/18A61K 31/495
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Application title
- TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING PRIMARY NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
- Applicant name
- Richter Gedeon Nyrt.
- Opponent name
- Wittkopp, Alexander
Krka, d.d., Novo mesto - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 54(2)European Patent Convention Art 56
- Keywords
- Sufficiency of disclosure - proof of the claimed therapeutic effect
Sufficiency of disclosure - post-published evidence
Sufficiency of disclosure - (yes)
Novelty - (yes)
Inventive step - reasonable expectation of success (no)
Amendments - added subject-matter (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed.